Post-treatment weight gain has been associated with a higher risk of recurrence and increased all-cause mortality among survivors
Well work closely with you to assess your medical history, discuss your weight loss goals, review potential side effects, and determine if Mounjaro is the right fit for you
Her decision to make a change was based on something entirely different
The GLP-1 agonists semaglutide and liraglutide, which seem new and therefore more risky, have been used for almost 20 years for people with type 2 diabetes and have been shown to be safe and well-tolerated, Levy says
The most common GLP-1 medications used for microdosing are: Semaglutide Tirzepatide Liraglutide Semaglutide microdosing Semaglutide microdosing is the practice of administering a weekly dose of the drug, often sold under brand names like Ozempic or Wegovy, that is substantially lower than the lowest FDA-approved starting dose of 0.25 milligrams (mg)